| P50 | author | Wyndham H. Wilson | Q110350523 |
| P2093 | author name string | Delong Liu | |
| | Nalini Raghavachari | |
| | Yihong Ye | |
| | Adrian Wiestner | |
| | Peter J Munson | |
| | Kieron Dunleavy | |
| | Marc A Weniger | |
| | Qiuyan Wang | |
| | Patricia Pérez-Galán | |
| | Edgar G Rizzatti | |
| | Megan M Tweito | |
| | Therese White | |
| P2860 | cites work | Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics | Q27851412 |
| | Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 |
| | An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements | Q28244853 |
| | Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma | Q28286125 |
| | ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells | Q28307506 |
| | PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress | Q28511471 |
| | CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum | Q28512249 |
| | Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway | Q29547371 |
| | An integrated stress response regulates amino acid metabolism and resistance to oxidative stress | Q29547441 |
| | Mediators of endoplasmic reticulum stress-induced apoptosis | Q29615496 |
| | IRE1 signaling affects cell fate during the unfolded protein response | Q29615502 |
| | ER stress triggers apoptosis by activating BH3-only protein Bim | Q29617730 |
| | Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma | Q33372761 |
| | Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes | Q33387817 |
| | Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells | Q33409161 |
| | High levels of Nrf2 determine chemoresistance in type II endometrial cancer | Q33959077 |
| | RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy | Q34759878 |
| | NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells | Q35850681 |
| | The role of the unfolded protein response in tumour development: friend or foe? | Q35968425 |
| | Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study | Q36117384 |
| | Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway | Q36313774 |
| | Proteasome inhibitors: antitumor effects and beyond | Q36649676 |
| | Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice | Q36732083 |
| | Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway | Q37062266 |
| | Building and operating an antibody factory: redox control during B to plasma cell terminal differentiation. | Q37074340 |
| | Proteasome inhibitors in cancer therapy: lessons from the first decade | Q37112347 |
| | Dual roles of Nrf2 in cancer | Q37119963 |
| | Mantle cell lymphoma: advances in biology and therapy | Q37184375 |
| | Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells | Q37291635 |
| | Therapy of mantle cell lymphoma: current standards and future strategies | Q37309647 |
| | Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species | Q37401266 |
| | Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathways | Q39993811 |
| | Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants | Q40273672 |
| | Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. | Q40291997 |
| | Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells | Q40310345 |
| | Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors | Q40558321 |
| | Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion | Q40669445 |
| | Genome-wide siRNA screen for modulators of cell death induced by proteasome inhibitor bortezomib | Q42164172 |
| | Redox homeostasis modulates the sensitivity of myeloma cells to bortezomib | Q43806000 |
| | Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells | Q44488098 |
| | Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentr | Q44712612 |
| | Dissecting tBHQ induced ARE-driven gene expression through long and short oligonucleotide arrays. | Q45197543 |
| | The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status | Q46706369 |
| | The Nrf2-Keap1-ARE signaling pathway: The regulation and dual function of Nrf2 in cancer. | Q51145746 |
| | Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma | Q59218456 |
| | ER stress signaling by regulated splicing: IRE1/HAC1/XBP1 | Q81604032 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5101-5112 | |
| P577 | publication date | 2011-06-28 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma | |
| P478 | volume | 17 | |